Home › Cancro colorettale › Ohio › Cincinnati
Studi clinici su Cancro colorettale a Cincinnati, OH
21 studi su Cancro colorettale cercano partecipanti presso sedi a Cincinnati e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal Cancer
In reclutamentoFase 3
- Oncology Hematology Care - Blue Ash /ID# 280143, Cincinnati
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
In reclutamentoStudio osservazionaleVolontari sani benvenuti
- Good Samaritan Hospital - Cincinnati, Cincinnati
- Oncology Hematology Care Inc-Kenwood, Cincinnati
- Bethesda North Hospital, Cincinnati
- e altri 3
Family Communications After Genetic Testing
In reclutamentoVolontari sani benvenuti
- University of Cincinnati Cancer Center-UC Medical Center, Cincinnati
- Good Samaritan Hospital - Cincinnati, Cincinnati
- Oncology Hematology Care Inc-Kenwood, Cincinnati
- e altri 4
Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastatic or Unresectable Cancers
In reclutamentoFase 1
- University of Cincinnati Cancer Center-UC Medical Center, Cincinnati
- University of Cincinnati Cancer Center-West Chester, West Chester · a 15 mi di distanza
A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer
In reclutamentoFase 2
- Oncology Hematology Care - Eastgate /ID# 271493, Cincinnati
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
In reclutamentoFase 3
- Oncology Hematology Care - Eastgate, Cincinnati
- Oncology Hematology Care Clinical Trials, LLC, Fairfield · a 15 mi di distanza
Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
In reclutamentoFase 2
- Research Site, Cincinnati
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
In reclutamentoFase 1/2
- University of Cincinnati Medical Center, Cincinnati
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
In reclutamentoFase 3
- University of Cincinnati Cancer Institute, Cincinnati
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
In reclutamentoFase 3
- Clinical Study Site, Cincinnati
- Clinical Study Site, Cincinnati
- Clinical Study Site, Edgewood · a 8 mi di distanza
A Phase 1 Study Evaluating DISP-10 in Participants With Advanced Gastrointestinal Cancers
In reclutamentoFase 1
- University of Cincinnati Cancer Center, Cincinnati
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
In reclutamentoFase 1/2
- Cincinnati Children's Hospital Medical Center, Cincinnati
MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors
In reclutamentoFase 1
- University of Cincinnati (UC) - Cancer Institute, Cincinnati
Testing the Addition of an Anti-Cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (5-Fluorouracil) for Metastatic, Refractory Colorectal Cancer
In reclutamentoFase 1
- University of Cincinnati Cancer Center-UC Medical Center, Cincinnati
- University of Cincinnati Cancer Center-West Chester, West Chester · a 15 mi di distanza
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
In reclutamentoFase 1/2
- Oncology Hematology Care Primary, Cincinnati
Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions
In reclutamentoFase 1/2
- University of Cincinnati Cancer Center, Cincinnati
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
In reclutamentoFase 1
- The Christ Hospital, Cincinnati
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
In reclutamentoFase 1/2
- Christ Hospital Cancer Center, Cincinnati
Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors
In reclutamentoFase 3Volontari sani benvenuti
- Good Samaritan Hospital - Cincinnati, Cincinnati
- Bethesda North Hospital, Cincinnati
- TriHealth Cancer Institute-Westside, Cincinnati
- e altri 1
64Cu-LNTH-1363S in Patients With Sarcoma or Gastrointestinal Tract Cancer
In reclutamentoFase 1/2
- Cincinnati Children's Hospital Medical Center, Cincinnati
Tempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays
In reclutamentoStudio osservazionale
- TriHealth Cancer Institute, Cincinnati
Studi su Cancro colorettale in altre città
- Houston, TX102 studi
- New York City, NY77 studi
- Nashville, TN69 studi
- Boston, MA63 studi
- Los Angeles, CA59 studi
- Arlington, VA52 studi
- St. Louis, MO50 studi
- San Antonio, TX46 studi
- Philadelphia, PA44 studi
- Grand Rapids, MI40 studi
- Baldwin Park, CA38 studi
- Seattle, WA34 studi
Altri studi a Cincinnati
- Cancro del polmone non a piccole cellule35 studi
- Cancro (tutti i tipi)27 studi
- Cancro al seno25 studi
- Insufficienza cardiaca24 studi
- Leucemia mieloide acuta20 studi
- Cancro metastatico20 studi
- Cancro ovarico19 studi
- Cancro ai polmoni19 studi
- Obesità19 studi
- Cancro alla prostata18 studi
- Mieloma multiplo17 studi
- Melanoma17 studi
Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.